{
    "1704057786730979808": {
        "attachments": {
            "media_keys": [
                "3_1704057782373163008"
            ]
        },
        "author_id": "5383942",
        "created_at": "2023-09-19T09:00:10.000Z",
        "edit_history_tweet_ids": [
            "1704057786730979808"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 47,
                    "normalized_text": "HIV",
                    "probability": 0.8229,
                    "start": 45,
                    "type": "Other"
                },
                {
                    "end": 66,
                    "normalized_text": "Europe",
                    "probability": 0.9709,
                    "start": 61,
                    "type": "Place"
                },
                {
                    "end": 113,
                    "normalized_text": "HIV",
                    "probability": 0.644,
                    "start": 111,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 19,
                    "start": 9,
                    "tag": "Investors"
                },
                {
                    "end": 30,
                    "start": 24,
                    "tag": "Media"
                }
            ],
            "mentions": [
                {
                    "end": 94,
                    "id": "3019793950",
                    "start": 87,
                    "username": "ViiVHC"
                }
            ],
            "urls": [
                {
                    "display_url": "gsk.to/3PIPb5x",
                    "end": 155,
                    "expanded_url": "https://gsk.to/3PIPb5x",
                    "start": 132,
                    "status": 200,
                    "unwound_url": "https://viivhealthcare.com/?linkId=100000219065812",
                    "url": "https://t.co/wpQVJhDldQ"
                },
                {
                    "display_url": "pic.twitter.com/FRoxacTvCP",
                    "end": 180,
                    "expanded_url": "https://twitter.com/GSK/status/1704057786730979808/photo/1",
                    "media_key": "3_1704057782373163008",
                    "start": 157,
                    "url": "https://t.co/FRoxacTvCP"
                }
            ]
        },
        "id": "1704057786730979808",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 2,
            "impression_count": 2380,
            "like_count": 2,
            "quote_count": 0,
            "reply_count": 0,
            "retweet_count": 3
        },
        "text": "News for #Investors and #Media regarding our HIV medicine in Europe, received today by @ViiVHC, our specialist HIV company. More at https://t.co/wpQVJhDldQ. https://t.co/FRoxacTvCP"
    }
}